(3S,4R)-3-(((Tert-butyldimethylsilyl)oxy)methyl)-4-(4-fluorophenyl)piperidine, 95%, 100mg

2-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 98%, 100mg

6-Quinoxalinecarboxylic acid, 97.0%, 5g

1-[(3aS,8aS)-tetrahydro-2,2-diMethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]- Piperidine, 98%, 100mg

(4R,4'R)-2,2'-[2-PHENYL-1-(PHENYLMETHYL)ETHYLIDENE]BIS[4-(1-METHYLETHYL)-4,5-DIHYDROOXAZOLE, 95%, 100mg

Pipettes jaugées 1 marquage, classe AS Petit emballage, 10 ml, 3 pièces

Methyl 2-Amino-3-chlorobenzoate>98.0%(GC)1g

6-BROMO-2-CHLORO-1-METHYL-1H-BENZO[D]IMIDAZOLE, 95.0%, 1g

2-(1H-2-Benzoimidazolyl)-ethylamine, 95.0%, 100g

3,4-Dimethoxy-2-nitrobenzaldehyde, 97%, 100mg

ETHYL 3-(4-MORPHOLINO)PROPIONATE, 95.0%, 5g

1-(4-FORMYLPHENYL)-1-OXO-5,8,11,14-TETRAOXA-2-AZAHEPTADECAN-17-OIC ACID, 95%, 1g

ethyl 1-(difluoromethyl)-1H-pyrazole-5-carboxylate, 250mg